It assumed AI’s trajectory is already set, that early effects can simply be measured and projected forward. What it missed is ...

Scott Fitzgerald's recent column discussing how Republicans are “solving the problems created by Obamacare” was clear ...

The launch of KlarnaUSD is a strategic move designed to fundamentally improve the company's long-term profitability by lowering operational costs. By creating its own payment infrastructure, Klarna is ...

The NBA is awash in a stunning gambling scandal with multiple former and current players arrested that has already led to one player’s banishment from the league forever, and alleged journalism outlet ...

The competition is heating up. The competition is heating up. is The Verge’s senior AI reporter. An AI beat reporter for more than five years, her work has also appeared in CNBC, MIT Technology Review ...

OpenAI on Tuesday said it had completed its recapitalization, splitting the AI lab into a for-profit corporation nested inside a non-profit foundation. It’s the end result of a complex legal process ...

The low-margin retail business, long criticized for thin returns, is masking high-growth segments like AWS and advertising. Amazon Web Services continues to post robust expansion, benefiting from ...

Nvidia Corporation's fundamentals remain robust in the near term, supporting continued investor optimism. Two significant challenges will likely limit NVDA's long-term growth potential despite current ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. BigBear.ai (NYSE:BBAI) shares are tumbling again, down ...

Engine OEMs, such as GE Aerospace with its LEAP engine, have become outsize beneficiaries of the dramatic rescaling of profit margins in aerospace recently. Credit: GE Aerospace The financial ...

Were you to glance at the trajectory of top AI stocks — OpenAI, Microsoft, Nvidia, and the like — you’d be convinced the industry is making money hand over fist. Look a bit deeper, however, and cracks ...

My estimations suggest that the U.S. government's cuts to its healthcare system will not have a significant negative impact on West Pharmaceutical's revenues. In Q2 2025, the company's revenues ...